Literature DB >> 9186429

The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy.

K P Cockerham1, C Pal, B Jani, A Wolter, J S Kennerdell.   

Abstract

PURPOSE: The authors determined the prevalence of ocular hypertension and its association with progression to glaucomatous damage in patients with thyroid-associated orbitopathy (TAO).
METHODS: The charts of 500 consecutive patients with TAO seen at the Allegheny General Hospital (Pittsburgh, PA) between 1985 and 1995 were analyzed. The amount of proptosis, degree and duration of myopathy, exposure to corticosteroids, prior glaucoma treatment, and family history of glaucoma were evaluated.
RESULTS: One hundred twenty (24%) patients with TAO were noted to have an intraocular pressure (IOP) greater than 22 mmHg but less than 30 mmHg. This ocular hypertensive group was composed of 34 men and 86 women with a mean age of 55 years and mean follow-up of 4 years. Seven patients were defined as glaucoma suspects, based on increased but nonprogressive cup-to-disc ratios or nonprogressive, atypical visual field changes in the presence of increased IOP. Two patients demonstrated progressive visual field abnormalities and cupping. Of the factors evaluated, only the duration of active orbital involvement was statistically associated with progression to glaucomatous damage. The mean duration of TAO was 3, 8, and 12 years for ocular hypertensives, glaucoma suspects, and glaucomatous damage, respectively.
CONCLUSIONS: Only a prolonged duration of active TAO in association with ocular hypertension correlated with progression to glaucomatous damage. These patients with chronic TAO deserve special attention and close follow-up to prevent optic nerve damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186429     DOI: 10.1016/s0161-6420(97)30207-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

Authors:  M B Kashkouli; F Pakdel; V Kiavash; I Heidari; A Heirati; S Jam
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

2.  The effect of orbital decompression surgery on refraction and intraocular pressure in patients with thyroid orbitopathy.

Authors:  J H Norris; J J Ross; M Kazim; D Selva; R Malhotra
Journal:  Eye (Lond)       Date:  2012-01-20       Impact factor: 3.775

3.  Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.

Authors:  Onur Konuk; Zafer Onaran; Suna Ozhan Oktar; Cem Yucel; Mehmet Unal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-16       Impact factor: 3.117

4.  The association between thyroid problems and glaucoma.

Authors:  J M Cross; C A Girkin; C Owsley; G McGwin
Journal:  Br J Ophthalmol       Date:  2008-10-16       Impact factor: 4.638

5.  Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy.

Authors:  R Kalmann; M P Mourits
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

6.  Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.

Authors:  F Brandt; M Thvilum; L Hegedüs; T H Brix
Journal:  Endocrine       Date:  2017-12-02       Impact factor: 3.633

7.  Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.

Authors:  Consuelo Pérez-Rico; Natividad Rodríguez-González; Juan Arévalo-Serrano; Román Blanco
Journal:  Doc Ophthalmol       Date:  2012-05-13       Impact factor: 2.379

8.  Biometric and refractive changes after orbital decompression in Korean patients with thyroid-associated orbitopathy.

Authors:  W S Kim; Y S Chun; B Y Cho; J K Lee
Journal:  Eye (Lond)       Date:  2015-11-20       Impact factor: 3.775

9.  Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.

Authors:  Yunhai Tu; Yilong Wang; Luna Ding; Jiao Zhang; Wencan Wu
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  Intraocular pressure and refractive changes following orbital decompression with intraconal fat excision.

Authors:  Suresh Sagili; Jean-Louis Desousa; Raman Malhotra
Journal:  Open Ophthalmol J       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.